Last reviewed · How we verify
NCT05664945: REPORT
Rethinking Pulmonary Rehabilitation - a Three-arm Randomised Multicentre Trial
NA trial testing pulmonary tele-rehabilitation (PTR) in Chronic Obstructive Pulmonary Disease in 180 participants. Participants enrolled and being followed up; not accepting new ones.
7 October 2025
Quick facts
| Lead sponsor | Copenhagen University Hospital, Hvidovre |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 10 January 2023 |
| Primary completion | 7 October 2025 |
| Estimated completion | 31 July 2027 |
| Sites | 7 locations across Denmark |
Drugs / interventions tested
- pulmonary tele-rehabilitation (PTR)
- home-based pulmonary rehabilitation (HPR)
- Control
Conditions studied
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
Sponsor
Copenhagen University Hospital, Hvidovre
Who can join
40 and older, any sex, with Chronic Obstructive Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pulmonary rehabilitation (PR) is one of the cornerstones of care for people with COPD together with smoking cessation and medical treatment. Despite the compelling evidence for its benefits, pulmonary rehabilitation is delivered to less than 30% of patients with COPD. Access to PR are particularly challenging, and especially for those with the most progressed stages of the disease. Pulmonary Tele-rehabilitation (PTR) and Home-based pulmonary rehabilitation (HPR) are two emerging models using health-care supportive technology that have proven equivalent to the conventional PR programs in patients with COPD who are able and willing to participate in conventional PR. However, much remain unknown regarding patients with COPD unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation. No studies have been conducted to specifically intervene towards this group. Response from emerging rehabilitation models for this specific group is a black box with no substantial research. To fulfill its potential of relevance, results from emerging models, such as Pulmonary Telerehabilitation and Home-based pulmonary rehabilitation must be of clinical relevance, and superior to the current 'usual care' (medication and scheduled follow-up control) in patients with COPD unable to access and participate in the conventional out-patient hospital- or community-based PR when offered during routine consultation.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Supervised pulmonary tele-rehabilitation and individualized home-based pulmonary rehabilitation for patients with COPD, unable to participate in center-based programs. The protocol for a multicenter randomized controlled trial - the REPORT study.
Nielsen C, Godtfredsen N, Molsted S, Ulrik C, et al · · 2025 · cited 5× · PMID 39774509 · DOI 10.1371/journal.pone.0312742 -
Why We Keep Going: A Qualitative Longitudinal Study of the Motivation and Engagement Among Patients with COPD During a Long-Term Danish Tele-Rehabilitation Program.
Olsen M, Nielsen C, Emme C, Godtfredsen NS, et al · · 2025 · PMID 41257245 · DOI 10.2147/ppa.s549332 -
Intra- and Inter-Rater Reproducibility of Measures of Physical Performance in Patients with COPD.
Nielsen C, Godtfredsen N, Molsted S, Ulrik C, et al · · 2025 · PMID 41095835 · DOI 10.3390/jcm14196755
Verify or expand the search:
- PubMed search for NCT05664945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of pulmonary tele-rehabilitation (PTR)
Trials testing the same drug.
- NCT06636487 — Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD · NA · active not recruiting
Other recruiting trials for Chronic Obstructive Pulmonary Disease
Currently open trials in the same condition.
- NCT06749262 — Inclined Versus Standard Exercise for COPD Patients · NA · recruiting
- NCT07406659 — Different Inspiratory Muscle Trainings in Patients With COPD · NA · recruiting
- NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting
- NCT07418736 — A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease · Phase 2 · recruiting
- NCT07069829 — Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo · recruiting
Other Copenhagen University Hospital, Hvidovre trials
Trials by the same sponsor.
- NCT07321379 — Efficacy of Bicarbonate on the Risk of Assisted Delivery in Nulliparous Women With Prolonged Labour · NA · not yet recruiting
- NCT07067060 — Risk of Serious Adverse Events Following Unsupervised vs Supervised Rehabilitation After Knee Arthroplasty · not yet recruiting
- NCT06967324 — GRACE - Graduated Response for Advanced COPD With Enhanced Support · NA · recruiting
- NCT06682260 — Evaluating the Effects of Nitroglycerin on Heart Function and Urinary Output in Patients With Acute Heart Failure · Phase 4 · completed
- NCT06866496 — Optimized Remission in Alcohol-related Liver Cirrhosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05664945 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital, Hvidovre
- Last refreshed: 6 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05664945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing